IDXX logo

IDEXX Laboratories, Inc. (IDXX) Cash and cash equivalents

annual cash & cash equivalents:

$288.27M-$165.67M(-36.50%)
December 31, 2024

Summary

  • As of today (August 25, 2025), IDXX annual cash & cash equivalents is $288.27 million, with the most recent change of -$165.67 million (-36.50%) on December 31, 2024.
  • During the last 3 years, IDXX annual cash & cash equivalents has risen by +$143.81 million (+99.56%).
  • IDXX annual cash & cash equivalents is now -38.98% below its all-time high of $472.41 million, reached on December 31, 2017.

Performance

IDXX Cash and cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIDXXbalance sheet metrics

quarterly cash & cash equivalents:

$164.59M+$624.00K(+0.38%)
June 30, 2025

Summary

  • As of today (August 25, 2025), IDXX quarterly cash & cash equivalents is $164.59 million, with the most recent change of +$624.00 thousand (+0.38%) on June 30, 2025.
  • Over the past year, IDXX quarterly cash & cash equivalents has dropped by -$237.00 million (-59.01%).
  • IDXX quarterly cash & cash equivalents is now -65.16% below its all-time high of $472.41 million, reached on December 31, 2017.

Performance

IDXX quarterly cash & cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIDXXbalance sheet metrics

Cash and cash equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

IDXX Cash and cash equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-36.5%-59.0%
3 y3 years+99.6%+43.9%
5 y5 years+219.1%+56.3%

IDXX Cash and cash equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-36.5%+156.1%-63.7%+66.0%
5 y5-year-36.5%+219.1%-63.7%+66.0%
alltimeall time-39.0%+1851.7%-65.2%+7381.6%

IDXX Cash and cash equivalents History

DateAnnualQuarterly
Jun 2025
-
$164.59M(+0.4%)
Mar 2025
-
$163.97M(-43.1%)
Dec 2024
$288.27M(-36.5%)
$288.27M(-6.6%)
Sep 2024
-
$308.64M(-23.1%)
Jun 2024
-
$401.59M(+1.0%)
Mar 2024
-
$397.43M(-12.4%)
Dec 2023
$453.93M(+303.3%)
$453.93M(+36.9%)
Sep 2023
-
$331.70M(+149.7%)
Jun 2023
-
$132.84M(+19.3%)
Mar 2023
-
$111.37M(-1.0%)
Dec 2022
$112.55M(-22.1%)
$112.55M(+13.5%)
Sep 2022
-
$99.18M(-13.3%)
Jun 2022
-
$114.36M(-44.1%)
Mar 2022
-
$204.62M(+41.6%)
Dec 2021
$144.45M(-62.4%)
$144.45M(-0.5%)
Sep 2021
-
$145.20M(-37.4%)
Jun 2021
-
$232.13M(-33.9%)
Mar 2021
-
$351.16M(-8.5%)
Dec 2020
$383.93M(+325.0%)
$383.93M(+118.7%)
Sep 2020
-
$175.59M(+66.8%)
Jun 2020
-
$105.29M(+29.4%)
Mar 2020
-
$81.39M(-9.9%)
Dec 2019
$90.33M(-27.0%)
$90.33M(-13.1%)
Sep 2019
-
$104.00M(-6.2%)
Jun 2019
-
$110.84M(-4.9%)
Mar 2019
-
$116.62M(-5.8%)
Dec 2018
$123.79M(-73.8%)
$123.79M(-15.7%)
Sep 2018
-
$146.88M(-15.9%)
Jun 2018
-
$174.56M(+9.6%)
Mar 2018
-
$159.23M(-66.3%)
Dec 2017
$472.41M(+17.9%)
$472.41M(+4.0%)
Sep 2017
-
$454.10M(+7.4%)
Jun 2017
-
$422.90M(+5.6%)
Mar 2017
-
$400.34M(-0.1%)
Dec 2016
$400.78M(+15.3%)
$400.78M(+2.4%)
Sep 2016
-
$391.47M(+5.7%)
Jun 2016
-
$370.20M(+5.6%)
Mar 2016
-
$350.57M(+0.9%)
Dec 2015
$347.46M(+3.8%)
$347.46M(-0.6%)
Sep 2015
-
$349.55M(+1.6%)
Jun 2015
-
$344.02M(+7.0%)
Mar 2015
-
$321.38M(-4.0%)
Dec 2014
$334.76M(+18.2%)
$334.76M(+14.4%)
Sep 2014
-
$292.74M(-4.0%)
Jun 2014
-
$305.05M(+6.6%)
Mar 2014
-
$286.20M(+1.1%)
Dec 2013
$283.10M(+26.4%)
$283.10M(+6.9%)
Sep 2013
-
$264.81M(+5.5%)
Jun 2013
-
$251.01M(+9.9%)
Mar 2013
-
$228.36M(+2.0%)
Dec 2012
$223.99M(+21.8%)
$223.99M(+1.1%)
Sep 2012
-
$221.44M(+9.7%)
Jun 2012
-
$201.81M(+8.8%)
Mar 2012
-
$185.49M(+0.9%)
Dec 2011
$183.90M
$183.90M(+1.3%)
Sep 2011
-
$181.50M(+13.9%)
DateAnnualQuarterly
Jun 2011
-
$159.40M(+3.9%)
Mar 2011
-
$153.46M(-2.2%)
Dec 2010
$156.91M(+47.0%)
$156.91M(+17.5%)
Sep 2010
-
$133.51M(+13.2%)
Jun 2010
-
$117.97M(+10.9%)
Mar 2010
-
$106.35M(-0.4%)
Dec 2009
$106.73M(+35.3%)
$106.73M(0.0%)
Sep 2009
-
$106.73M(+2.9%)
Jun 2009
-
$103.74M(+20.2%)
Mar 2009
-
$86.30M(+9.4%)
Dec 2008
$78.87M(+30.7%)
$78.87M(-6.8%)
Sep 2008
-
$84.59M(+12.4%)
Jun 2008
-
$75.27M(+25.0%)
Mar 2008
-
$60.22M(-0.2%)
Dec 2007
$60.36M(-37.6%)
$60.36M(+3.2%)
Sep 2007
-
$58.51M(+18.0%)
Jun 2007
-
$49.59M(-8.1%)
Mar 2007
-
$53.94M(-44.2%)
Dec 2006
$96.67M(-27.2%)
$96.67M(+2.2%)
Sep 2006
-
$94.59M(+22.8%)
Jun 2006
-
$77.06M(-17.1%)
Mar 2006
-
$93.00M(-29.9%)
Dec 2005
$132.73M(-6.8%)
$132.73M(+2.5%)
Sep 2005
-
$129.46M(-1.1%)
Jun 2005
-
$130.96M(+18.8%)
Mar 2005
-
$110.20M(-11.3%)
Mar 1999
-
$124.31M(-27.9%)
Sep 1998
-
$172.43M(+4.3%)
Jun 1998
-
$165.31M(+20.2%)
Mar 1998
-
$137.58M(+28.6%)
Dec 1997
$142.47M(-17.9%)
$107.00M(+1.4%)
Sep 1997
-
$105.50M(-11.5%)
Jun 1997
-
$119.20M(+8.6%)
Mar 1997
-
$109.80M(-14.0%)
Dec 1996
$173.64M(-5.5%)
$127.70M(+1.8%)
Sep 1996
-
$125.50M(-10.0%)
Jun 1996
-
$139.40M(+8.3%)
Mar 1996
-
$128.70M(-13.8%)
Dec 1995
$183.66M(+264.3%)
$149.30M(-19.6%)
Sep 1995
-
$185.80M(+489.8%)
Jun 1995
-
$31.50M(-9.2%)
Mar 1995
-
$34.70M(+37.7%)
Dec 1994
$50.41M(+28.0%)
$25.20M(+22.3%)
Sep 1994
-
$20.60M(-8.0%)
Jun 1994
-
$22.40M(+1.4%)
Mar 1994
-
$22.10M(+16.9%)
Dec 1993
$39.40M(+26.4%)
$18.90M(-12.5%)
Sep 1993
-
$21.60M(+0.5%)
Jun 1993
-
$21.50M(+7.5%)
Mar 1993
-
$20.00M(+16.3%)
Dec 1992
$31.18M(+111.1%)
$17.20M(+30.3%)
Sep 1992
-
$13.20M(+14.8%)
Jun 1992
-
$11.50M(+422.7%)
Mar 1992
-
$2.20M(-76.3%)
Dec 1991
$14.77M
$9.30M(-9.7%)
Sep 1991
-
$10.30M(-50.5%)
Jun 1991
-
$20.80M

FAQ

  • What is IDEXX Laboratories, Inc. annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for IDEXX Laboratories, Inc.?
  • What is IDEXX Laboratories, Inc. annual cash & cash equivalents year-on-year change?
  • What is IDEXX Laboratories, Inc. quarterly cash & cash equivalents?
  • What is the all time high quarterly cash & cash equivalents for IDEXX Laboratories, Inc.?
  • What is IDEXX Laboratories, Inc. quarterly cash & cash equivalents year-on-year change?

What is IDEXX Laboratories, Inc. annual cash & cash equivalents?

The current annual cash & cash equivalents of IDXX is $288.27M

What is the all time high annual cash & cash equivalents for IDEXX Laboratories, Inc.?

IDEXX Laboratories, Inc. all-time high annual cash & cash equivalents is $472.41M

What is IDEXX Laboratories, Inc. annual cash & cash equivalents year-on-year change?

Over the past year, IDXX annual cash & cash equivalents has changed by -$165.67M (-36.50%)

What is IDEXX Laboratories, Inc. quarterly cash & cash equivalents?

The current quarterly cash & cash equivalents of IDXX is $164.59M

What is the all time high quarterly cash & cash equivalents for IDEXX Laboratories, Inc.?

IDEXX Laboratories, Inc. all-time high quarterly cash & cash equivalents is $472.41M

What is IDEXX Laboratories, Inc. quarterly cash & cash equivalents year-on-year change?

Over the past year, IDXX quarterly cash & cash equivalents has changed by -$237.00M (-59.01%)
On this page